Heart Failure With Reduced Ejection Fraction in a Patient With Erdheim-Chester Disease on Dabrafenib
A 54-year-old woman with a diagnosis of Erdheim-Chester disease under therapy with dabrafenib presents with clinical signs of heart failure. After discontinuing the offending medication and initiating guideline-directed medical therapy for heart failure with reduced ejection fraction, the clinical p...
Saved in:
Published in | JACC. Case reports Vol. 29; no. 12; p. 102374 |
---|---|
Main Authors | , , , , , , , |
Format | Report |
Language | English |
Published |
19.06.2024
|
Online Access | Get full text |
Cover
Loading…
Summary: | A 54-year-old woman with a diagnosis of Erdheim-Chester disease under therapy with dabrafenib presents with clinical signs of heart failure. After discontinuing the offending medication and initiating guideline-directed medical therapy for heart failure with reduced ejection fraction, the clinical picture improved. |
---|---|
Bibliography: | ObjectType-Case Study-2 content type line 59 SourceType-Reports-1 ObjectType-Report-1 |
ISSN: | 2666-0849 |
DOI: | 10.1016/j.jaccas.2024.102374 |